BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12369606)

  • 1. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of norepinephrine in depression.
    Delgado PL; Moreno FA
    J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
    Tritschler L; Gaillard R; Gardier AM; David DJ; Guilloux JP
    Encephale; 2018 Jun; 44(3):264-273. PubMed ID: 29801770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
    Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
    CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine involvement in antidepressant action.
    Frazer A
    J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Domino principle--monoamines in bottom-view].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Jun; 10(3):131-40. PubMed ID: 18956617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD; Cavanaugh JE; Lakoski JM
    CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action.
    Potter WZ
    J Clin Psychiatry; 1996; 57 Suppl 4():4-8. PubMed ID: 8636064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual-action hypothesis: does pharmacology matter?
    Shelton RC
    J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in mechanism of action between current and future antidepressants.
    Stahl SM; Grady MM
    J Clin Psychiatry; 2003; 64 Suppl 13():13-7. PubMed ID: 14552651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.
    Schildkraut JJ; Mooney JJ
    Am J Psychiatry; 2004 May; 161(5):909-11. PubMed ID: 15121658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM
    J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.